Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Nature Reviews. Cardiology
|
February 22, 2012
Oral factor Xa inhibitors for the long-term management of ACS
James W Wisler, Richard C Becker
Expert Opinion on Therapeutic Targets
|
October 28, 2014
Antithrombotic therapy: new areas to understand efficacy and bleeding
James W Wisler, Richard C Becker
Critical Pathways in Cardiology
|
May 19, 2012
A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillation
James W Wisler, Richard C Becker
Journal of Thrombosis and Thrombolysis
|
September 19, 2013
Emerging paradigms in arterial thrombosis
James W Wisler, Richard C Becker
Nucleic Acids Research
|
May 11, 2006
Probing the DNA sequence specificity of Escherichia coli RECA protein
Rakhi Rajan, James W Wisler, Charles E Bell
Journal of Thrombosis and Thrombolysis
|
January 25, 2012
Evaluation of dose requirements for prolonged bivalirudin administration in patients with renal insufficiency and suspected heparin-induced thrombocytopenia
James W Wisler, Jeffrey B Washam, Richard C Becker
Circulation
|
May 31, 2018
Biased G Protein-Coupled Receptor Signaling: Changing the Paradigm of Drug Discovery
James W Wisler, Howard A Rockman, Robert J Lefkowitz
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
July 28, 2010
The diversity of wound presentation associated with freon contact frostbite injury
James W Wisler, Jonathan R Wisler, Rebecca Coffey, et al.
Personalized Medicine
|
May 18, 2018
Challenges and opportunities in implementing pharmacogenomics testing in the clinics
Jon R Wisler, James W Wisler, Shelly Bansal, et al.
Current Opinion in Cell Biology
|
April 1, 2014
Recent developments in biased agonism
James W Wisler, Kunhong Xiao, Alex R B Thomsen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Nature Reviews. Cardiology
|
February 22, 2012
Oral factor Xa inhibitors for the long-term management of ACS
James W Wisler, Richard C Becker
Expert Opinion on Therapeutic Targets
|
October 28, 2014
Antithrombotic therapy: new areas to understand efficacy and bleeding
James W Wisler, Richard C Becker
Critical Pathways in Cardiology
|
May 19, 2012
A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillation
James W Wisler, Richard C Becker
Journal of Thrombosis and Thrombolysis
|
September 19, 2013
Emerging paradigms in arterial thrombosis
James W Wisler, Richard C Becker
Nucleic Acids Research
|
May 11, 2006
Probing the DNA sequence specificity of Escherichia coli RECA protein
Rakhi Rajan, James W Wisler, Charles E Bell
Journal of Thrombosis and Thrombolysis
|
January 25, 2012
Evaluation of dose requirements for prolonged bivalirudin administration in patients with renal insufficiency and suspected heparin-induced thrombocytopenia
James W Wisler, Jeffrey B Washam, Richard C Becker
Circulation
|
May 31, 2018
Biased G Protein-Coupled Receptor Signaling: Changing the Paradigm of Drug Discovery
James W Wisler, Howard A Rockman, Robert J Lefkowitz
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
July 28, 2010
The diversity of wound presentation associated with freon contact frostbite injury
James W Wisler, Jonathan R Wisler, Rebecca Coffey, et al.
Personalized Medicine
|
May 18, 2018
Challenges and opportunities in implementing pharmacogenomics testing in the clinics
Jon R Wisler, James W Wisler, Shelly Bansal, et al.
Current Opinion in Cell Biology
|
April 1, 2014
Recent developments in biased agonism
James W Wisler, Kunhong Xiao, Alex R B Thomsen, et al.
Page
of 2